Replimune Group, Inc. (REPL) Earnings
NASDAQ·Healthcare·Biotechnology
$5.24
-2.15%
Mkt Cap $878.07M
EPS — Estimate vs Actual
Mkt Cap
$878.07M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$3.58
NASDAQ·Healthcare·Biotechnology
$5.24
-2.15%
Mkt Cap $878.07M
Mkt Cap
$878.07M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$3.58